Detection of Clinically Relevant Pain Relief in Cats with Degenerative Joint Disease Associated Pain
Journal of Veterinary Internal Medicine2014Vol. 28(2), pp. 346–350
Citations Over TimeTop 10% of 2014 papers
Abstract
Using both a client-specific and a general clinical metrology instrument, owners of cats with DJD were able to detect evident recurrence of clinical signs after withdrawal of active medication than after withdrawal of placebo, and that this study design might be a novel and useful way to circumvent the placebo effect and detect the efficacy of pain-relieving medications.
Related Papers
- → Pharmacokinetic properties of low-dose SoluMatrix meloxicam in healthy adults(2015)8 cited
- → Influence on analgesic activity and serum levels after meloxicam complexation with beta-cyclodextrin in mice and rats(2011)4 cited
- → Evaluation of Meloxicam as Stress Modulator in Cases of Assisted Parturition in Buffaloes(2018)1 cited
- CASE REPORT : OSTEOARTHRITIS(2013)
- [The selective cox-2 inhibitor meloxicam and salicylate therapy].(2005)